2016 ISAPP共识声明:益生元的定义和范围

2016-12-01 Nat Rev Gastroenterol Hepatol. 2017 Jun 14.

2016年12月,国际益生菌和益生元科学会(ISAPP)专家小组回顾了益生元的相关定义和范围,形成共识文件,该共识的主要目的是确保益生元术语的正确应用,及其相关产品的应用和监管。

中文标题:

2016 ISAPP共识声明:益生元的定义和范围

英文标题:

Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics.

发布机构:

发布日期:

2016-12-01

简要介绍:

2016年12月,国际益生菌和益生元科学会(ISAPP)专家小组回顾了益生元的相关定义和范围,形成共识文件,该共识的主要目的是确保益生元术语的正确应用,及其相关产品的应用和监管。


拓展指南:消化相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2016 ISAPP共识声明:益生元的定义和范围)] GetToolGuiderByIdResponse(projectId=1, id=98f951c001a55840, title=2016 ISAPP共识声明:益生元的定义和范围, enTitle=Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics., guiderFrom=Nat Rev Gastroenterol Hepatol. 2017 Jun 14., authorId=null, author=, summary=2016年12月,国际益生菌和益生元科学会(ISAPP)专家小组回顾了益生元的相关定义和范围,形成共识文件,该共识的主要目的是确保益生元术语的正确应用,及其相关产品的应用和监管。, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Thu Dec 01 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2016年12月,国际益生菌和益生元科学会(ISAPP)专家小组回顾了益生元的相关定义和范围,形成共识文件,该共识的主要目的是确保益生元术语的正确应用,及其相关产品的应用和监管。 <div><br> </div> 拓展指南:<strong>与<font color=red>消化</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=adce11c001a538ff" title="非酒精性脂肪性肝病的治疗—欧洲肥胖-2型糖尿病-消化临床实践指南解读" target=_blank>非酒精性脂肪性肝病的治疗—欧洲肥胖-2型糖尿病-消化临床实践指南解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=893f11c001a09493" title="消化道肿瘤多学科综合治疗协作组诊疗模式专家共识" target=_blank>消化道肿瘤多学科综合治疗协作组诊疗模式专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=3d9ad1c0013e610b" title="2017 UK指南:青少年慢性消化系统疾病患者向成人过度时期的管理" target=_blank>2017 UK指南:青少年慢性消化系统疾病患者向成人过度时期的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=e96db1c00132e80d" title="中国消化内镜中心安全运行专家共识意见" target=_blank>中国消化内镜中心安全运行专家共识意见</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=1c5961c00130360f" title="2016 NICE指南:16岁及以上人群上呼吸消化道肿瘤的评估和管理(NG.36)" target=_blank>2016 NICE指南:16岁及以上人群上呼吸消化道肿瘤的评估和管理(NG.36)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E6%B6%88%E5%8C%96" target=_blank>有关消化更多指南</a></ul>, tagList=[TagDto(tagId=21065, tagName=益生元), TagDto(tagId=17974, tagName=定义), TagDto(tagId=31446, tagName=范围)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=34, categoryName=全科医学, tenant=100), CategoryDto(categoryId=35, categoryName=预防医学, tenant=100), CategoryDto(categoryId=95, categoryName=康复医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4772, appHits=126, showAppHits=0, pcHits=3509, showPcHits=2081, likes=111, shares=5, comments=3, approvalStatus=1, publishedTime=Fri Jun 16 11:01:13 CST 2017, publishedTimeString=2016-12-01, pcVisible=1, appVisible=1, editorId=5295982, editor=yanqin, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yanqin, createdTime=Fri Jun 16 11:01:13 CST 2017, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 15:44:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 ISAPP共识声明:益生元的定义和范围)])
2016 ISAPP共识声明:益生元的定义和范围
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=921294, encodeId=2f5f92129483, content=haohao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfe5086704, createdName=145c4a54m26暂无昵称, createdTime=Sat Jan 30 10:22:36 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217089, encodeId=aa4a21e089bf, content=感谢分享!继续关注!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Fri Jun 30 13:14:12 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211813, encodeId=fd16211813ad, content=感动你好东西学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Jun 17 07:43:31 CST 2017, time=2017-06-17, status=1, ipAttribution=)]
    2021-01-30 145c4a54m26暂无昵称

    haohao

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=921294, encodeId=2f5f92129483, content=haohao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfe5086704, createdName=145c4a54m26暂无昵称, createdTime=Sat Jan 30 10:22:36 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217089, encodeId=aa4a21e089bf, content=感谢分享!继续关注!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Fri Jun 30 13:14:12 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211813, encodeId=fd16211813ad, content=感动你好东西学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Jun 17 07:43:31 CST 2017, time=2017-06-17, status=1, ipAttribution=)]
    2017-06-30 明天会更好!

    感谢分享!继续关注!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=921294, encodeId=2f5f92129483, content=haohao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfe5086704, createdName=145c4a54m26暂无昵称, createdTime=Sat Jan 30 10:22:36 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=217089, encodeId=aa4a21e089bf, content=感谢分享!继续关注!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Fri Jun 30 13:14:12 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211813, encodeId=fd16211813ad, content=感动你好东西学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Jun 17 07:43:31 CST 2017, time=2017-06-17, status=1, ipAttribution=)]
    2017-06-17 thlabcde

    感动你好东西学习了!

    0